Cancer Causes & Control

, Volume 20, Issue 4, pp 491–496 | Cite as

Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium

  • Sara H. Olson
  • Chu Chen
  • Immaculata De Vivo
  • Jennifer A. Doherty
  • Virginia Hartmuller
  • Pamela L. Horn-Ross
  • James V. LaceyJr.
  • Shannon M. Lynch
  • Leah Sansbury
  • V. Wendy Setiawan
  • Leo J. Schouten
  • Xiao Ou Shu
Brief Report

Abstract

Endometrial cancer affects more than 40,000 women a year in the U.S. While the association of this disease with high body mass index and sex steroid hormones is well known, there are many questions about etiology that have not been resolved. Little is known about the genetic basis for risk associated with hormones or obesity, other common genetic factors associated with risk, or gene–environment interactions. E2C2, the Epidemiology of Endometrial Cancer Consortium, was formed in 2006 to provide a collaborative environment for addressing these questions by pooling data from existing studies. This allows for investigations of uncommon risk factors, risk for rare histologic subtypes, and associations within strata that cannot be achieved in individual studies. This report describes the establishment of the consortium, ongoing projects that demonstrate the advantages of collaborative efforts, and challenges faced. Overall, the consortium promises to provide an important means of furthering our knowledge about this cancer.

Keywords

Endometrial cancer Epidemiology 

Notes

Acknowledgments

We thank the Robert Howard Family Foundation for its gift to MSKCC that enabled the establishment of the E2C2 database. We thank Dana Christo, Heather Feigelson, Marc Goodman, Timothy Rebbeck, Daniela Seminara, Elisabete Weiderpass, and Anne Zeleniuch-Jacquotte for their participation in the development of E2C2.

Supplementary material

References

  1. 1.
    American Cancer Society (2008) Cancer facts and figures 2008. American Cancer Society, AtlantaGoogle Scholar
  2. 2.
    Key TJ, Pike MC (1988) The dose-effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57(2):205–212PubMedGoogle Scholar
  3. 3.
    Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA et al (1996) Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88(16):1127–1135. doi:10.1093/jnci/88.16.1127 Aug 21PubMedCrossRefGoogle Scholar
  4. 4.
    Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S et al (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108(3):425–432. doi:10.1002/ijc.11529 PubMedCrossRefGoogle Scholar
  5. 5.
    Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, Li HL, Wen W, Ji BT, Li Q, Shu XO, Gao YT (2005) The Shanghai Women’s Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 162(11):1123–1131. doi:10.1093/aje/kwi322 PubMedCrossRefGoogle Scholar
  6. 6.
    Kolonel LN, Altshuler D, Henderson BE (2004) The Multiethnic Cohort Study: exploring genes, lifestyle and cancer risk. Nat Rev 4(7):519–527Google Scholar
  7. 7.
    Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D et al (2003) A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 12(20):2679–2692. doi:10.1093/hmg/ddg294 PubMedCrossRefGoogle Scholar
  8. 8.
    Berstein LM, Imyanitov EN, Kovalevskij AJ, Maximov SJ, Vasilyev DA, Buslov KG et al (2004) CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Cancer Lett 207(2):191–196. doi:10.1016/j.canlet.2004.01.001 PubMedCrossRefGoogle Scholar
  9. 9.
    Paynter RA, Hankinson SE, Colditz GA, Kraft P, Hunter DJ, De Vivo I (2005) CYP19 (aromatase) haplotypes and endometrial cancer risk. Int J Cancer 116(2):267–274. doi:10.1002/ijc.21041 PubMedCrossRefGoogle Scholar
  10. 10.
    Tao MH, Cai Q, Zhang ZF, Xu WH, Kataoka N, Wen W et al (2007) Polymorphisms in the CYP19A1 (Aromatase) gene and endometrial cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 16(5):943–949. doi:10.1158/1055-9965.EPI-06-1012 PubMedCrossRefGoogle Scholar
  11. 11.
    Olson SH, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K et al (2008) Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control. Apr 25 (Epub ahead of print)Google Scholar
  12. 12.
    Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G et al (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67(5):1893–1897. doi:10.1158/0008-5472.CAN-06-4123 PubMedCrossRefGoogle Scholar
  13. 13.
    Setiawan VW, Doherty JA, Shu X, Akbari MR, Chen C, De Vivo I et al (2009) Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in E2C2. Cancer Epidemiol Biomarkers Prev 18(1):242–247PubMedCrossRefGoogle Scholar
  14. 14.
    Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN (1997) Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146(4):294–306PubMedGoogle Scholar
  15. 15.
    Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM (2003) Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95(15):1158–1164PubMedCrossRefGoogle Scholar
  16. 16.
    Xu WH, Dai Q, Xiang YB, Long JR, Ruan ZX, Cheng JR et al (2007) Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 7(12):1420–1430. doi:10.1093/aje/kwm242 CrossRefGoogle Scholar
  17. 17.
    Sherman ME, Sturgeon S, Brinton LA, Potischman N, Kurman RJ, Berman ML et al (1997) Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 10(10):963–968PubMedGoogle Scholar
  18. 18.
    Bjorge T, Engeland A, Tretli S, Weiderpass E (2007) Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120(2):378–383. doi:10.1002/ijc.22260 PubMedCrossRefGoogle Scholar
  19. 19.
    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DCGoogle Scholar
  20. 20.
    Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N et al (2008) Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 121(6):501–508. doi:10.1016/j.amjmed.2008.01.044 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Sara H. Olson
    • 1
  • Chu Chen
    • 2
    • 3
    • 4
  • Immaculata De Vivo
    • 5
    • 6
  • Jennifer A. Doherty
    • 2
  • Virginia Hartmuller
    • 7
  • Pamela L. Horn-Ross
    • 8
  • James V. LaceyJr.
    • 9
  • Shannon M. Lynch
    • 7
  • Leah Sansbury
    • 7
  • V. Wendy Setiawan
    • 10
  • Leo J. Schouten
    • 11
  • Xiao Ou Shu
    • 12
    • 13
    • 14
  1. 1.Department of Epidemiology and BiostatisticsMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Program in Epidemiology, Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA
  3. 3.Department of Epidemiology, School of Public Health and Community MedicineUniversity of WashingtonSeattleUSA
  4. 4.Department of Otolaryngology: Head and Neck Surgery, School of MedicineUniversity of WashingtonSeattleUSA
  5. 5.Channing Laboratory, Department of MedicineBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA
  6. 6.Department of EpidemiologyHarvard School of Public HealthBostonUSA
  7. 7.Epidemiology & Genetics Research Program, Division of Cancer Control and Population SciencesNational Cancer InstituteBethesdaUSA
  8. 8.Northern California Cancer CenterFremontUSA
  9. 9.Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and GeneticsNational Cancer InstituteRockvilleUSA
  10. 10.Department of Preventive Medicine, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  11. 11.Department of Epidemiology, GROW – School for Oncology and Developmental BiologyMaastricht UniversityMaastrichtThe Netherlands
  12. 12.Vanderbilt Epidemiology CenterVanderbilt Institute of Medicine and Public HealthNashvilleUSA
  13. 13.Department of MedicineVanderbilt University Medical CenterNashvilleUSA
  14. 14.Vanderbilt-Ingram Cancer CenterNashvilleUSA

Personalised recommendations